Cargando…

Incidence of Tumour Progression and Pseudoprogression in High-Grade Gliomas: a Systematic Review and Meta-Analysis

BACKGROUND: High-grade gliomas are the most common primary brain tumours. Pseudoprogression describes the false appearance of radiation-induced progression on MRI. A distinction should be made from true tumour progression to correctly plan treatment. However, there is wide variation of reported pseu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abbasi, Abdul W., Westerlaan, Henriette E., Holtman, Gea A., Aden, Kamal M., van Laar, Peter Jan, van der Hoorn, Anouk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105173/ https://www.ncbi.nlm.nih.gov/pubmed/28466127 http://dx.doi.org/10.1007/s00062-017-0584-x

Ejemplares similares

Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with head and neck tumors, a systematic review and meta-analysis
por: van der Hoorn, Anouk, et al.
Publicado: (2017)

Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with high-grade glioma, a systematic review and meta-analysis
por: van Dijken, Bart R. J., et al.
Publicado: (2017)

Pseudoprogression in low-grade glioma
por: Slater, Jason M., et al.
Publicado: (2019)

Discriminators of pseudoprogression and true progression in high-grade gliomas: A systematic review and meta-analysis
por: Taylor, Chris, et al.
Publicado: (2022)

Recent Application of Advanced MR Imaging to Predict Pseudoprogression in High-grade Glioma Patients
por: YOO, Roh-EUL, et al.
Publicado: (2015)

Radiomics for pseudoprogression prediction in high grade gliomas: added value of MR contrast agent
por: Mammadov, Orkhan, et al.
Publicado: (2022)

Inter-observer reproducibility of quantitative dynamic susceptibility contrast and diffusion MRI parameters in histogram analysis of gliomas
por: Dijkstra, Hildebrand, et al.
Publicado: (2019)

Retrospective examination of pseudoprogression in IDH mutant gliomas
por: Wetzel, Ethan A, et al.
Publicado: (2023)

Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma()
por: Bronk, Julianna K., et al.
Publicado: (2018)

Neutrophil–lymphocyte ratio dynamics are useful for distinguishing between recurrence and pseudoprogression in high-grade gliomas
por: Huang, Yong, et al.
Publicado: (2019)

Multimodal MRI-Based Radiomic Nomogram for the Early Differentiation of Recurrence and Pseudoprogression of High-Grade Glioma
por: Jing, Hui, et al.
Publicado: (2022)

Radiomics: The New Promise for Differentiating Progression, Recurrence, Pseudoprogression, and Radionecrosis in Glioma and Glioblastoma Multiforme
por: Alizadeh, Mohammadreza, et al.
Publicado: (2023)

Pseudoprogression of brain tumors
por: Thust, Stefanie C., et al.
Publicado: (2018)

Voxel based morphometry-detected white matter volume loss after multi-modality treatment in high grade glioma patients
por: de Groot, Jesse D., et al.
Publicado: (2023)

FET PET Radiomics for Differentiating Pseudoprogression from Early Tumor Progression in Glioma Patients Post-Chemoradiation
por: Lohmann, Philipp, et al.
Publicado: (2020)

Dynamic Susceptibility Perfusion Imaging for Differentiating Progressive Disease from Pseudoprogression in Diffuse Glioma Molecular Subtypes
por: Richter, Vivien, et al.
Publicado: (2021)

Pseudoprogression prediction in high grade primary CNS tumors by use of radiomics
por: Ari, Asena Petek, et al.
Publicado: (2022)

Pseudoprogression and Pseudoresponse in the Management of High-Grade Glioma : Optimal Decision Timing According to the Response Assessment of the Neuro-Oncology Working Group
por: Chang, Ji Hyun, et al.
Publicado: (2014)

The value of MGMT promote methylation and IDH-1 mutation on diagnosis of pseudoprogression in patients with high-grade glioma: A meta-analysis
por: Zhou, Min, et al.
Publicado: (2019)

Multiple oligodendroglioma with pseudoprogression
por: Matsuyama, Junko
Publicado: (2012)

Pseudoprogression and Immunotherapy Phenomena
por: Waxman, Elizabeth S., et al.
Publicado: (2020)

Discriminating pseudoprogression and true progression in diffuse infiltrating glioma using multi-parametric MRI data through deep learning
por: Lee, Joonsang, et al.
Publicado: (2020)

Radiation Necrosis, Pseudoprogression, Pseudoresponse, and Tumor Recurrence: Imaging Challenges for the Evaluation of Treated Gliomas
por: Zikou, Anastasia, et al.
Publicado: (2018)

Prediction of Pseudoprogression versus Progression using Machine Learning Algorithm in Glioblastoma
por: Jang, Bum-Sup, et al.
Publicado: (2018)

Glioblastoma pseudoprogression and true progression reveal spatially variable transcriptional differences
por: Wang, Wesley, et al.
Publicado: (2023)

Differentiating tumour progression from pseudoprogression in glioblastoma patients: a monoexponential, biexponential, and stretched-exponential model-based DWI study
por: Liao, Dan, et al.
Publicado: (2023)

The diagnostic performance of perfusion MRI for differentiating glioma recurrence from pseudoprogression: A meta-analysis
por: Wan, Bing, et al.
Publicado: (2017)

(11)C-methyl-L-methionine PET measuring parameters for the diagnosis of tumour progression against radiation-induced changes in brain metastases
por: Govaerts, Chris W., et al.
Publicado: (2021)

Functional MRI for Treatment Evaluation in Patients with Head and Neck Squamous Cell Carcinoma: A Review of the Literature from a Radiologist Perspective
por: Nooij, Roland P., et al.
Publicado: (2018)

Unsupervised consensus cluster analysis of [18F]-fluoroethyl-L-tyrosine positron emission tomography identified textural features for the diagnosis of pseudoprogression in high-grade glioma
por: Kebir, Sied, et al.
Publicado: (2016)

Pseudoprogression as an adverse event of glioblastoma therapy
por: Balaña, Carmen, et al.
Publicado: (2017)

Pseudoprogression with Neoadjuvant Immunotherapy for Cutaneous Melanoma
por: Garcia, Diogo, et al.
Publicado: (2021)

Defining Treatment‐Related Adverse Effects in Patients with Glioma: Distinctive Features of Pseudoprogression and Treatment‐Induced Necrosis
por: Winter, Sebastian F., et al.
Publicado: (2020)

Blood Biomarkers of Glioma in Response Assessment Including Pseudoprogression and Other Treatment Effects: A Systematic Review
por: Raza, Istafa J., et al.
Publicado: (2020)

Differentiation of pseudoprogression and real progression in glioblastoma using ADC parametric response maps
por: Reimer, Caroline, et al.
Publicado: (2017)

The predictive value of absolute lymphocyte counts on tumor progression and pseudoprogression in patients with glioblastoma
por: Xi, Jing, et al.
Publicado: (2021)

The Value of Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in the Differentiation of Pseudoprogression and Recurrence of Intracranial Gliomas
por: Jing, Hui, et al.
Publicado: (2022)

Diagnostic accuracy of glioma pseudoprogression identification with positron emission tomography imaging: a systematic review and meta-analysis
por: Ouyang, Zhi-Qiang, et al.
Publicado: (2023)

A case report of pseudoprogression followed by complete remission after proton-beam irradiation for a low-grade glioma in a teenager: the value of dynamic contrast-enhanced MRI
por: Meyzer, Candice, et al.
Publicado: (2010)

RARE-15. EARLY PSEUDOPROGRESSION POST-RADIATION IN PAEDIATRIC HIGH-GRADE GLIOMA PATIENTS WITH CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY: TWO CASE REPORTS FROM A SINGLE CENTRE
por: Teng, Ay-Jiuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a5a080vfa92hc3734bod8udngi